Gijs Hardenberg
Janssen (Netherlands)(NL)BBB Therapeutics (Netherlands)(NL)
Publications by Year
Research Areas
Immune Response and Inflammation, Immune Cell Function and Interaction, T-cell and B-cell Immunology, Inflammatory Bowel Disease, Immunotherapy and Immune Responses
Most-Cited Works
- → Dynamic programming of CD8+ T lymphocyte responses(2003)397 cited
- → Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses(2020)370 cited
- → Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation(2005)216 cited
- → APRIL promotes B-1 cell-associated neoplasm(2004)159 cited
- → The role of T‐regulatory cells and Toll‐like receptors in the pathogenesis of human inflammatory bowel disease(2008)152 cited
- → Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets(2011)113 cited
- → The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization andcross‐linking(2009)83 cited
- → Specific TLR ligands regulate APRIL secretion by dendritic cells in a PKR‐dependent manner(2007)62 cited
- → TLR5 is not required for flagellin-mediated exacerbation of DSS colitis(2009)56 cited
- → The uncertain glory of APRIL(2003)53 cited